Keyphrases
Parkinson's Disease
100%
5-aminolevulinate
50%
Constipation
50%
Multi-session
50%
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
50%
Heme Precursors
50%
Myelin Formation
50%
Gut-brain Axis
50%
Tremor
50%
Schwann Cells
50%
Drug-induced Tremor
50%
Anorectal Function
50%
Dichloroacetate
33%
Lipids
33%
Lithium
25%
Clinical Practice
25%
Antipsychotics
25%
Bronchodilator
25%
Management Strategy
25%
Symptomatic Patients
25%
Amiodarone
25%
Antidepressants
25%
Valproic Acid
25%
Motor Evoked Potential Latency
18%
Protein Carbonyls
16%
Oxidative Stress Markers
16%
Glial Cells
16%
Porphyria
16%
Neuronal Cells
16%
Hydroxynonenal
16%
Pro-oxidant
16%
Mitochondrial Respiratory Chain
16%
Tyrosinemia Type 1
16%
Myelin Protein Zero
16%
Investigational Drugs
16%
Malondialdehyde
16%
Antioxidant Properties
16%
Myelin
16%
Peripheral Neuropathy
16%
Neurological Complications
16%
Peripheral Myelin Protein 22 (PMP22)
16%
Sensory Neurons
16%
5-Aminolevulinic Acid (5-ALA)
16%
Age-adjusted
13%
Cortical Evoked Potentials
13%
Severe Constipation
13%
Sensory Threshold
13%
Moderate to Severe
9%
Parkinson's Disease Model
9%
Gastrointestinal Diseases
9%
Medicine and Dentistry
Parkinson's Disease
100%
Bronchodilating Agent
50%
Vagus Nerve Stimulation
50%
Typical Antipsychotic
50%
Gut
50%
Amiodarone
50%
Sodium Valproate
50%
Clinician
50%
Antidepressant
50%
Constipation
50%
Motor Evoked Potential
20%
Evoked Cortical Response
12%
Perceptive Threshold
12%
Symptom
11%
Gastrointestinal Distress
8%
Sensation
8%
Unified Parkinson's Disease Rating Scale
7%
Myelodysplastic Syndrome
7%
Adverse Event
7%
Neuroscience
Myelinogenesis
50%
Heme
50%
Parkinson's Disease
50%
Aminolevulinic Acid
50%
Alpha-Linolenic Acid
50%
Schwann Cell
25%
Motor Evoked Potential
20%
Oxidizing Agent
16%
Evoked Cortical Response
12%
Protein Carbonylation
8%
Porphyria
8%
Myelin
8%
Oxidative Stress
8%
Electron Transport Chain
8%
Glial Cells
8%
Peripheral Neuropathy
8%
Sensory Neuron
8%
Myelin Protein
8%
Peripheral Myelin Protein 22
8%